Letter
February 13, 2023 Letter: BMA Responds to the CY 2024 Medicare Advantage Proposed Policy & Technical Change Rule
BMA submits the following comments on the proposed CY 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs.